Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-08-07
2007-08-07
Kennedy, Sharon (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
11387454
ABSTRACT:
A method and product are provided for the treatment of connective tissue weakened due to destruction of tissue architecture, and in particular due to elastin degradation. The treatment agents employ certain unique properties of phenolic compounds to develop a protocol for reducing elastin degradation, such as that occurring during aneurysm formation in vasculature. According to the invention, elastin can be stabilized in vivo and destruction of connective tissue, such as that leading to life-threatening aneurysms in vasculature, can be tempered or halted all together. The treatment agents can be delivered or administered acutely or chronically according to various delivery methods, including sustained release methods incorporating perivascular or endovascular patches, use of microsphere carriers, hydrogels, or osmotic pumps.
REFERENCES:
patent: 4992264 (1991-02-01), Diot et al.
patent: 5015677 (1991-05-01), Benedict et al.
patent: 5720950 (1998-02-01), Poiani et al.
patent: 5750150 (1998-05-01), Okazaki et al.
patent: 5876744 (1999-03-01), Della Valle et al.
patent: 5968500 (1999-10-01), Robinson
patent: 5972999 (1999-10-01), Murad
patent: 6146616 (2000-11-01), Msika et al.
patent: 6235294 (2001-05-01), Perrier et al.
patent: 6239114 (2001-05-01), Guthrie et al.
patent: 6254898 (2001-07-01), Bragaglia
patent: 6432922 (2002-08-01), Brunck et al.
patent: 6437004 (2002-08-01), Perricone
patent: 6444234 (2002-09-01), Kirby et al.
patent: 6469053 (2002-10-01), Romanczyk, Jr. et al.
patent: 6471973 (2002-10-01), Perrier et al.
patent: 6517824 (2003-02-01), Kohn et al.
patent: 6576613 (2003-06-01), Brunck et al.
patent: 6586405 (2003-07-01), Semple et al.
patent: 6610320 (2003-08-01), Schmitz et al.
patent: 6630163 (2003-10-01), Murad
patent: 6676977 (2004-01-01), Murad
patent: 6747059 (2004-06-01), Romanczyk, Jr. et al.
patent: 6787152 (2004-09-01), Kirby et al.
patent: 6800292 (2004-10-01), Murad
patent: 6830577 (2004-12-01), Nash et al.
patent: 6867188 (2005-03-01), Qvist et al.
patent: 6927205 (2005-08-01), Patt
patent: 6927206 (2005-08-01), Patt
patent: 6929626 (2005-08-01), DiCarlo et al.
patent: 2003/0171287 (2003-09-01), Morishita et al.
patent: 2003/0228364 (2003-12-01), Nathan
patent: 2005/0079202 (2005-04-01), Chen et al.
Article—Aneurysm of the Rabbit Common Carotid Artery Induced by Periarterial Application of Calcium Chloride In Vivo,Gertz et al., J. Clin. Invest., vol. 81, Mar. 1988, pp. 649-656.
Book—Antinutrients and Phytochemicals in Foods(Methods for determination of condensed and hydrolysable tannins), Hagerman et al., Shahadi, F., Ed., Washington, DC, American Chemical Society, 1997, pp. 209-222.
Article—Elastin fragments drive disease progression in a murine model of emphysema,Houghton et al., The Journal of Clinical Investigation, vol. 116, No. 3, Mar. 2006, pp. 753-759.
Article—Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid,Isenburg et al., Biomaterials 25, 2004, pp. 3293-3302.
Article—Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic Aneurysm,Freestone, et al., Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, 1995, pp. 1145-1151.
Article—Influence of Hypercholesterolemia and Adventitial Inflammation on the Development of Aortic Aneurysm in Rabbits,Freestone, et al., Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, 1997, pp. 10-17.
Article—Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas,Brem et al., Journal of Neurosurgery, vol. 74, No. 3, Mar. 1991, pp. 441-446.
Article—Pharmaceutical Salts,Berge et al., Journal of Pharmaceutical Sciences, vol. 66, No. 1, Jan. 1977, pp. 1-19.
Article—Provocation of experimental aortic inflammation and dilation by inflammatory mediators and Chlamydia pneumoniae,Tambiah et al., British Journal of Surgery, vol. 88; 200!, pp. 935-940.
Article—Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall,Isenburg et al., Biomaterials 26, 2005, pp. 1237-1245.
Search Report and Written Opinion for PCT/US06/13090, Sep. 25, 2006.
Isenburg Jason C.
Simionescu Dan T.
Vyavahare Narendra R.
Clemson University Research Foundation (CURF)
Dority & Manning P.A.
Kennedy Sharon
LandOfFree
Elastin stabilization of connective tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Elastin stabilization of connective tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Elastin stabilization of connective tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3832409